WEBSTER BANK, N. A. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 64 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
WEBSTER BANK, N. A. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$18,828
+0.2%
1,5270.0%0.00%
+50.0%
Q2 2023$18,782
+0.1%
1,5270.0%0.00%0.0%
Q1 2023$18,767
+110294.1%
1,5270.0%0.00%0.0%
Q4 2022$17
-99.8%
1,527
-50.0%
0.00%0.0%
Q3 2022$11,000
-38.9%
3,0550.0%0.00%0.0%
Q2 2022$18,000
-5.3%
3,0550.0%0.00%0.0%
Q1 2022$19,000
+58.3%
3,0550.0%0.00%
+100.0%
Q4 2021$12,000
-20.0%
3,0550.0%0.00%
-50.0%
Q3 2021$15,000
-25.0%
3,0550.0%0.00%0.0%
Q2 2021$20,000
+5.3%
3,0550.0%0.00%0.0%
Q1 2021$19,000
-9.5%
3,0550.0%0.00%0.0%
Q4 2020$21,000
+75.0%
3,0550.0%0.00%0.0%
Q3 2020$12,000
+20.0%
3,0550.0%0.00%
+100.0%
Q2 2020$10,000
+42.9%
3,0550.0%0.00%0.0%
Q1 2020$7,000
-30.0%
3,0550.0%0.00%0.0%
Q4 2019$10,000
-28.6%
3,0550.0%0.00%
-50.0%
Q3 2019$14,000
-22.2%
3,0550.0%0.00%0.0%
Q2 2019$18,000
-14.3%
3,0550.0%0.00%
-33.3%
Q1 2019$21,000
+75.0%
3,0550.0%0.00%
+50.0%
Q4 2018$12,000
-25.0%
3,0550.0%0.00%0.0%
Q3 2018$16,000
+6.7%
3,0550.0%0.00%0.0%
Q2 2018$15,000
-40.0%
3,0550.0%0.00%
-50.0%
Q1 2018$25,000
-19.4%
3,0550.0%0.00%0.0%
Q4 2017$31,0003,0550.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Western Standard LLC 1,063,267$4,253,0004.83%
22NW, LP 1,241,896$4,968,0002.52%
Newtyn Management, LLC 1,296,436$5,186,0001.26%
Bronte Capital Management Pty Ltd. 531,510$2,052,0000.36%
WITTENBERG INVESTMENT MANAGEMENT, INC. 186,198$620,0000.33%
Nantahala Capital Management 751,943$3,008,0000.09%
Sepio Capital, LP 194,785$779,0000.08%
Yakira Capital Management, Inc. 66,934$268,0000.08%
LVW Advisors, LLC 20,000$80,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,700$247,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders